Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 823821, 27 pages
http://dx.doi.org/10.1155/2010/823821
Review Article

Regulation of I 𝜅 B 𝛼 Function and NF- 𝜅 B Signaling: AEBP1 Is a Novel Proinflammatory Mediator in Macrophages

1Department of Biology and Chemistry, Faculty of Arts and Sciences, American University of Sharjah, P.O. Box 26666, Sharjah, UAE
2Department of Biochemistry and Molecular Biology, Faculty of Medicine, Sir Charles Tupper Medical Building, Dalhousie University, Halifax, NS, B3H 1X5, Canada

Received 17 November 2009; Accepted 12 January 2010

Academic Editor: Hidde Bult

Copyright © 2010 Amin Majdalawieh and Hyo-Sung Ro. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Baeuerle, “Pro-inflammatory signaling: last pieces in the NF-κB puzzle?” Current Biology, vol. 8, no. 1, pp. R19–R22, 1998. View at Google Scholar · View at Scopus
  2. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Google Scholar · View at Scopus
  3. Y. Yamamoto and R. B. Gaynor, “Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer,” Journal of Clinical Investigation, vol. 107, no. 2, pp. 135–142, 2001. View at Google Scholar · View at Scopus
  4. S. E. Shoelson, J. Lee, and M. Yuan, “Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance,” The International Journal of Obesity, vol. 27, supplement 3, pp. S49–S52, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H. Clevers, “At the crossroads of inflammation and cancer,” Cell, vol. 118, no. 6, pp. 671–674, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Kumar, Y. Takada, A. M. Boriek, and B. B. Aggarwal, “Nuclear factor-κB: its role in health and disease,” The Journal of Molecular Medicine, vol. 82, no. 7, pp. 434–448, 2004. View at Google Scholar · View at Scopus
  7. C. Monaco and E. Paleolog, “Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis,” Cardiovascular Research, vol. 61, no. 4, pp. 671–682, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. P. A. Baeuerle and D. Baltimore, “IκB: a specific inhibitor of the NF-κB transcription factor,” Science, vol. 242, no. 4878, pp. 540–546, 1988. View at Google Scholar · View at Scopus
  9. M. J. May and S. Ghosh, “Rel/NF-κB and IκB proteins: an overview,” Seminars in Cancer Biology, vol. 8, no. 2, pp. 63–73, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Ghosh, M. J. May, and E. B. Kopp, “NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses,” Annual Review of Immunology, vol. 16, pp. 225–260, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. N. Wilcox, K. M. Smith, S. M. Schwartz, and D. Gordon, “Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 8, pp. 2839–2843, 1989. View at Google Scholar · View at Scopus
  12. P. Barath, M. C. Fishbein, J. Cao, J. Berenson, R. H. Helfant, and J. S. Forrester, “Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization,” American Journal of Pathology, vol. 137, no. 3, pp. 503–509, 1990. View at Google Scholar · View at Scopus
  13. K. Brand, B. J. Fowler, T. S. Edgington, and N. Mackman, “Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide,” Molecular and Cellular Biology, vol. 11, no. 9, pp. 4732–4738, 1991. View at Google Scholar · View at Scopus
  14. M. I. Cybulsky and M. A. Gimbrone Jr., “Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis,” Science, vol. 251, no. 4995, pp. 788–791, 1991. View at Google Scholar · View at Scopus
  15. N. Mackman, K. Brand, and T. S. Edgington, “Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites,” Journal of Experimental Medicine, vol. 174, no. 6, pp. 1517–1526, 1991. View at Google Scholar · View at Scopus
  16. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. A. Baeuerle and T. Henkel, “Function and activation of NF-κB in the immune system,” Annual Review of Immunology, vol. 12, pp. 141–179, 1994. View at Google Scholar · View at Scopus
  18. E. B. Kopp and S. Ghosh, “NF-κB and Rel proteins in innate immunity,” Advances in Immunology, vol. 58, pp. 1–27, 1995. View at Google Scholar · View at Scopus
  19. A. S. Baldwin Jr., “The NF-κB and IκB proteins: new discoveries and insights,” Annual Review of Immunology, vol. 14, pp. 649–683, 1996. View at Google Scholar · View at Scopus
  20. T. Yokoo and M. Kitamura, “Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1,” American Journal of Physiology, vol. 270, pp. F123–F130, 1996. View at Google Scholar
  21. J. A. Mengshol, M. P. Vincenti, C. I. Coon, A. Barchowsky, and C. E. Brinckerhoff, “Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3,” Arthritis and Rheumatism, vol. 43, no. 4, pp. 801–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. W. C. Sha, H. C. Liou, E. I. Tuomanen, and D. Baltimore, “Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses,” Cell, vol. 80, no. 2, pp. 321–330, 1995. View at Google Scholar · View at Scopus
  23. J. H. Caamaño, C. A. Rizzo, S. K. Durham et al., “Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses,” Journal of Experimental Medicine, vol. 187, no. 2, pp. 185–196, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Franzoso, L. Carlson, L. Poljak et al., “Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture,” Journal of Experimental Medicine, vol. 187, no. 2, pp. 147–159, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore, “Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB,” Nature, vol. 376, no. 6536, pp. 167–170, 1995. View at Google Scholar · View at Scopus
  26. T. S. Doi, T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata, “NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses,” Journal of Experimental Medicine, vol. 185, no. 5, pp. 953–961, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Alcamo, J. P. Mizgerd, B. H. Horwitz et al., “Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment,” Journal of Immunology, vol. 167, no. 3, pp. 1592–1600, 2001. View at Google Scholar · View at Scopus
  28. F. Kontgen, R. J. Grumont, A. Strasser et al., “Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression,” Genes & Development, vol. 9, no. 16, pp. 1965–1977, 1995. View at Google Scholar · View at Scopus
  29. F. Weih, D. Carrasco, S. K. Durham et al., “Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family,” Cell, vol. 80, no. 2, pp. 331–340, 1995. View at Google Scholar · View at Scopus
  30. K. Brand, S. Page, G. Rogler et al., “Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1715–1722, 1996. View at Google Scholar · View at Scopus
  31. C. Kaltschmidt, B. Kaltschmidt, J. Lannes-Vieira et al., “Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 55, no. 1, pp. 99–106, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Parhami, Z. T. Fang, A. M. Fogelman, A. Andalibi, M. C. Territo, and J. A. Berliner, “Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate,” Journal of Clinical Investigation, vol. 92, no. 1, pp. 471–478, 1993. View at Google Scholar · View at Scopus
  33. H.-B. Peng, T. B. Rajavashisth, P. Libby, and J. K. Liao, “Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells,” Journal of Biological Chemistry, vol. 270, no. 28, pp. 17050–17055, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. T. B. Rajavashisth, H. Yamada, and N. K. Mishra, “Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL: involvement of nuclear factor-κB,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 10, pp. 1591–1598, 1995. View at Google Scholar · View at Scopus
  35. K. Brand, T. Eisele, U. Kreusel et al., “Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 1901–1909, 1997. View at Google Scholar · View at Scopus
  36. K. Brand, S. Page, A. K. Walli, D. Neumeier, and P. A. Baeuerle, “Role of nuclear factor-κB in atherogenesis,” Experimental Physiology, vol. 82, no. 2, pp. 297–304, 1997. View at Google Scholar · View at Scopus
  37. S. Wolfrum, D. Teupser, M. Tan, K. Y. Chen, and J. L. Breslow, “The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18601–18606, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. Gareus, E. Kotsaki, S. Xanthoulea et al., “Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis,” Cell Metabolism, vol. 8, no. 5, pp. 372–383, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. K. M. Kim, J. Y. Choi, S.-E. Yoo et al., “HMCO5, herbal extract, inhibits NF-κB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 316–324, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. L. Wang, C. Geng, L. Jiang et al., “The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis,” European Journal of Nutrition, vol. 47, no. 5, pp. 235–243, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. Wang, R. Zhang, Y. Xu, H. Zhou, B. Wang, and S. Li, “Genistein inhibits the development of atherosclerosis via inhibiting NF-κB and VCAM-1 expression in LDLR knockout mice,” Canadian Journal of Physiology and Pharmacology, vol. 86, no. 11, pp. 777–784, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. Y. Liu, F. Yan, Y. Liu et al., “Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation,” Phytotherapy Research, vol. 22, no. 7, pp. 935–942, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. H. Li, M. Dai, and W. Jia, “Paeonol attenuates high-fat-diet-induced atherosclerosis in rabbits by anti-inflammatory activity,” Planta Medica, vol. 75, no. 1, pp. 7–11, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. V. H. Thourani, S. S. Brar, T. P. Kennedy et al., “Nonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury,” American Journal of Physiology, vol. 278, no. 6, pp. H2084–H2093, 2000. View at Google Scholar · View at Scopus
  45. H. Sasaki, P. S. Ray, L. Zhu, N. Galang, and N. Maulik, “Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFκB,” Toxicology, vol. 155, no. 1–3, pp. 27–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Sasaki, P. S. Ray, L. Zhu, H. Otani, T. Asahara, and N. Maulik, “Hypoxia/reoxygenation promotes myocardial angiogenesis via an NFκB-dependent mechanism in a rat model of chronic myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 2, pp. 283–294, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. Yoshiyama, T. Omura, K. Takeuchi et al., “Angiotensin blockade inhibits increased JNKs, AP-1 and NFκB DNA-binding activities in myocardial infarcted rats,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 4, pp. 799–810, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. T. Izumi, Y. Saito, I. Kishimoto et al., “Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-κB activation and alleviates myocardial ischemia/reperfusion injury,” Journal of Clinical Investigation, vol. 108, no. 2, pp. 203–213, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Shimizu, M. Tamamori-Adachi, H. Arai, N. Tabuchi, H. Tanaka, and M. Sunamori, “Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory κBα complex and attenuation of nuclear factor κB,” Journal of Thoracic and Cardiovascular Surgery, vol. 124, no. 5, pp. 933–941, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Thiemermann, “Inhibition of the activation of nuclear factor κB to reduce myocardial reperfusion injury and infarct size,” Cardiovascular Research, vol. 63, no. 1, pp. 8–10, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. L. Lu, S. S. Chen, J. Q. Zhang, F. J. Ramires, and Y. Sun, “Activation of nuclear factor-κB and its proinflammatory mediator cascade in the infarcted rat heart,” Biochemical and Biophysical Research Communications, vol. 321, no. 4, pp. 879–885, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. I. M. Verma, J. K. Stevenson, E. M. Schwarz, D. van Antwerp, and S. Miyamoto, “Rel/NF-κB/IκB family: intimate tales of association and dissociation,” Genes & Development, vol. 9, no. 22, pp. 2723–2735, 1995. View at Google Scholar · View at Scopus
  53. K. Kawakami, C. Scheidereit, and R. G. Roeder, “Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 13, pp. 4700–4704, 1988. View at Google Scholar · View at Scopus
  54. P. A. Baeuerle and D. Baltimore, “A 65-κD subunit of active NF-κB is required for inhibition of NF-κB by IκB,” Genes & Development, vol. 3, no. 11, pp. 1689–1698, 1989. View at Google Scholar · View at Scopus
  55. S. Ghosh, A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore, “Cloning of the p50 DNA binding subunit of NF-κB: homology to Rel and dorsal,” Cell, vol. 62, no. 5, pp. 1019–1029, 1990. View at Publisher · View at Google Scholar · View at Scopus
  56. U. Zabel, R. Schreck, and P. A. Baeuerle, “DNA binding of purified transcription factor NF-κB. Affinity, specificity, Zn2+ dependence, and differential half-site recognition,” Journal of Biological Chemistry, vol. 266, no. 1, pp. 252–260, 1991. View at Google Scholar · View at Scopus
  57. S.-M. Kang, A.-C. Tran, M. Grilli, and M. J. Lenardo, “NF-κB subunit regulation in nontransformed CD4+ T lymphocytes,” Science, vol. 256, no. 5062, pp. 1452–1455, 1992. View at Google Scholar · View at Scopus
  58. D. Plaksin, P. A. Baeuerle, and L. Eisenbach, “KBF1 (p50 NF-κB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells,” Journal of Experimental Medicine, vol. 177, no. 6, pp. 1651–1662, 1993. View at Google Scholar · View at Scopus
  59. A. M. Brown, M. W. Linhoff, B. Stein et al., “Function of NF-κB/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-κB/Rel subunits,” Molecular and Cellular Biology, vol. 14, no. 5, pp. 2926–2935, 1994. View at Google Scholar · View at Scopus
  60. W. S. Blair, H. P. Bogerd, S. J. Madore, and B. R. Cullen, “Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module,” Molecular and Cellular Biology, vol. 14, no. 11, pp. 7226–7234, 1994. View at Google Scholar · View at Scopus
  61. P. Dobrzanski, R. P. Ryseck, and R. Bravo, “Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif,” Molecular and Cellular Biology, vol. 13, no. 3, pp. 1572–1582, 1993. View at Google Scholar · View at Scopus
  62. S. Ghosh and D. Baltimore, “Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB,” Nature, vol. 344, no. 6267, pp. 678–682, 1990. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. A. Israel, “The IKK complex: an integrator of all signals that activate NF-κB?” Trends in Cell Biology, vol. 10, no. 4, pp. 129–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. M. S. Hayden and S. Ghosh, “Signaling to NF-κB,” Genes & Development, vol. 18, no. 18, pp. 2195–2224, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. G. Mosialos, P. Hamer, A. J. Capobianco, R. A. Laursen, and T. D. Gilmore, “A protein kinase-A recognition sequence is structurally linked to transformation by p59(v-rel) and cytoplasmic retention of p68(c-rel),” Molecular and Cellular Biology, vol. 11, no. 12, pp. 5867–5877, 1991. View at Google Scholar · View at Scopus
  66. J. L. Norris and J. L. Manley, “Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase A,” Genes & Development, vol. 6, no. 9, pp. 1654–1667, 1992. View at Google Scholar · View at Scopus
  67. M. Naumann and C. Scheidereit, “Activation of NF-κB in vivo is regulated by multiple phosphorylations,” EMBO Journal, vol. 13, no. 19, pp. 4597–4607, 1994. View at Google Scholar · View at Scopus
  68. C. C. H. Li, R. M. Dai, E. Chen, and D. L. Longo, “Phosphorylation of NF-κB1-p50 is involved in NF-κB activation and stable DNA binding,” Journal of Biological Chemistry, vol. 269, no. 48, pp. 30089–30092, 1994. View at Google Scholar · View at Scopus
  69. C. C. H. Li, M. Korner, D. K. Ferris, E. Chen, R. M. Dai, and D. L. Longo, “NF-κB/Rel family members are physically associated phosphoproteins,” Biochemical Journal, vol. 303, no. 2, pp. 499–506, 1994. View at Google Scholar · View at Scopus
  70. H. Zhong, H. SuYang, H. Erdjument-Bromage, P. Tempst, and S. Ghosh, “The transcriptional activity of NF-κB is regulated by the IκB- associated PKAc subunit through a cyclic AMP-independent mechanism,” Cell, vol. 89, no. 3, pp. 413–424, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Vermeulen, G. De Wilde, P. van Damme, W. Vanden Berghe, and G. Haegeman, “Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1),” EMBO Journal, vol. 22, pp. 1313–1324, 2003. View at Google Scholar
  72. H. Zhong, R. E. Voll, and S. Ghosh, “Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300,” Molecular Cell, vol. 1, no. 5, pp. 661–671, 1998. View at Google Scholar · View at Scopus
  73. H. Zhong, M. J. May, E. Jimi, and S. Ghosh, “The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1,” Molecular Cell, vol. 9, no. 3, pp. 625–636, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Duran, M. T. Diaz-Meco, and J. Moscat, “Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcriptional activation,” EMBO Journal, vol. 22, no. 15, pp. 3910–3918, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. D. Wang, S. D. Westerheide, J. L. Hanson, and A. S. Baldwin Jr., “Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II,” Journal of Biological Chemistry, vol. 275, no. 42, pp. 32592–32597, 2000. View at Google Scholar · View at Scopus
  76. H. Sakurai, H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi, “IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain,” Journal of Biological Chemistry, vol. 274, no. 43, pp. 30353–30356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. X. Jiang, N. Takahashi, N. Matsui, T. Tetsuka, and T. Okamoto, “The NF-κB activation in lymphotoxin β receptor signaling depends on the phosphorylation of p65 at serine 536,” Journal of Biological Chemistry, vol. 278, no. 2, pp. 919–926, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. A. M. O'Mahony, M. Montano, K. van Beneden, L.-F. Chen, and W. C. Greene, “Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65,” Journal of Biological Chemistry, vol. 279, no. 18, pp. 18137–18145, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. L. V. Madrid, M. W. Mayo, J. Y. Reuther, and A. S. Baldwin Jr., “Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38,” Journal of Biological Chemistry, vol. 276, no. 22, pp. 18934–18940, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. N. Sizemore, S. Leung, and G. R. Stark, “Activation of phosphatidylinositol 3-kinase in response to interleukin- 1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit,” Molecular and Cellular Biology, vol. 19, no. 7, pp. 4798–4805, 1999. View at Google Scholar · View at Scopus
  81. J. Bohuslav, L.-F. Chen, H. Kwon, Y. Mu, and W. C. Greene, “p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1,” Journal of Biological Chemistry, vol. 279, no. 25, pp. 26115–26125, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. F. Fujita, Y. Taniguchi, T. Kato et al., “Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling,” Molecular and Cellular Biology, vol. 23, no. 21, pp. 7780–7793, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Buss, A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht, “Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription,” Journal of Biological Chemistry, vol. 279, no. 53, pp. 55633–55643, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. F. Logeat, N. Israel, R. Ten et al., “Inhibition of transcription factors belonging to the rel/NF-κB family by a transdominant negative mutant,” EMBO Journal, vol. 10, no. 7, pp. 1827–1832, 1991. View at Google Scholar · View at Scopus
  85. S. M. Ruben, R. Narayanan, J. F. Klement, C.-H. Chen, and C. A. Rosen, “Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative,” Molecular and Cellular Biology, vol. 12, no. 2, pp. 444–454, 1992. View at Google Scholar · View at Scopus
  86. P. A. Ganchi, S.-C. Sun, W. C. Greene, and D. W. Ballard, “A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization,” Molecular and Cellular Biology, vol. 13, no. 12, pp. 7826–7835, 1993. View at Google Scholar · View at Scopus
  87. R.-P. Ryseck, J. Novotny, and R. Bravo, “Characterization of elements determining the dimerization properties of RelB and p50,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3100–3109, 1995. View at Google Scholar · View at Scopus
  88. C. Kunsch, S. M. Ruben, and C. A. Rosen, “Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation,” Molecular and Cellular Biology, vol. 12, no. 10, pp. 4412–4421, 1992. View at Google Scholar · View at Scopus
  89. N. R. Rice, M. L. MacKichan, and A. Israel, “The precursor of NF-κB p50 has IκB-like functions,” Cell, vol. 71, no. 2, pp. 243–253, 1992. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Bressler, K. Brown, W. Timmer, V. Bours, U. Siebenlist, and A. S. Fauci, “Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant p50 mutants,” Journal of Virology, vol. 67, no. 1, pp. 288–293, 1993. View at Google Scholar · View at Scopus
  91. P. A. Baeuerle and D. Baltimore, “Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor,” Cell, vol. 53, no. 2, pp. 211–217, 1988. View at Google Scholar · View at Scopus
  92. U. Zabel and P. A. Baeuerle, “Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA,” Cell, vol. 61, no. 2, pp. 255–265, 1990. View at Publisher · View at Google Scholar · View at Scopus
  93. S. T. Whiteside and A. Israel, “IκB proteins: structure, function and regulation,” Seminars in Cancer Biology, vol. 8, no. 2, pp. 75–82, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. G. Totzke, F. Essmann, S. Pohlmann, C. Lindenblatt, R. U. Janicke, and K. Schulze-Osthoff, “A novel member of the IκB family, human IκBζ, inhibits transactivation of p65 and its DNA binding,” Journal of Biological Chemistry, vol. 281, no. 18, pp. 12645–12654, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. Q. Zhang, J. A. Didonato, M. Karin, and T. W. Mckeithan, “BCL3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins,” Molecular and Cellular Biology, vol. 14, no. 6, pp. 3915–3926, 1994. View at Google Scholar · View at Scopus
  96. G. Franzoso, V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist, “The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition,” Nature, vol. 359, no. 6393, pp. 339–342, 1992. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. G. Franzoso, V. Bours, V. Azarenko et al., “The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites,” EMBO Journal, vol. 12, no. 10, pp. 3893–3901, 1993. View at Google Scholar · View at Scopus
  98. J. Inoue, T. Takahara, T. Akizawa, and O. Hino, “Bcl-3, a member of the IκB proteins, has distinct specificity towards the Rel family of proteins,” Oncogene, vol. 8, no. 8, pp. 2067–2073, 1993. View at Google Scholar · View at Scopus
  99. S. Haskill, A. A. Beg, S. M. Tompkins et al., “Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity,” Cell, vol. 65, no. 7, pp. 1281–1289, 1991. View at Google Scholar · View at Scopus
  100. N. Davis, S. Ghosh, D. L. Simmons et al., “Rel-associated pp40: an inhibitor of the Rel family of transcription factors,” Science, vol. 253, no. 5025, pp. 1268–1271, 1991. View at Google Scholar · View at Scopus
  101. A. A. Beg and A. S. Baldwin Jr., “The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors,” Genes & Development, vol. 7, no. 11, pp. 2064–2070, 1993. View at Google Scholar · View at Scopus
  102. L. Breeden and K. Nasmyth, “Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila,” Nature, vol. 329, no. 6140, pp. 651–654, 1987. View at Google Scholar · View at Scopus
  103. S. E. Lux, K. M. John, and V. Bennett, “Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins,” Nature, vol. 344, no. 6261, pp. 36–42, 1990. View at Google Scholar · View at Scopus
  104. P. Michaely and V. Bennett, “The ANK repeat: a ubiquitous motif involved in macromolecular recognition,” Trends in Cell Biology, vol. 2, no. 5, pp. 127–129, 1992. View at Google Scholar · View at Scopus
  105. J. Q. Davis and V. Bennett, “The anion exchanger and Na+K+-ATPase interact with distinct sites on ankyrin in in vitro assays,” Journal of Biological Chemistry, vol. 265, no. 28, pp. 17252–17256, 1990. View at Google Scholar · View at Scopus
  106. E. N. Hatada, A. Nieters, F. G. Wulczyn et al., “The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene Bcl-3 act as specific inhibitors of NF-κB DNA binding,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2489–2493, 1992. View at Google Scholar · View at Scopus
  107. J.-I. Inoue, L. D. Kerr, D. Rashid, N. Davis, H. R. Bose Jr., and I. M. Verma, “Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 10, pp. 4333–4337, 1992. View at Publisher · View at Google Scholar · View at Scopus
  108. P. A. Ganchi, S.-C. Sun, W. C. Greene, and D. W. Ballard, “IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding,” Molecular Biology of the Cell, vol. 3, no. 12, pp. 1339–1352, 1992. View at Google Scholar · View at Scopus
  109. M. K. Ernst, L. L. Dunn, and N. R. Rice, “The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers,” Molecular and Cellular Biology, vol. 15, no. 2, pp. 872–882, 1995. View at Google Scholar · View at Scopus
  110. P. Beauparlant, R. Lin, and J. Hiscott, “The role of the C-terminal domain of IκBα in protein degradation and stabilization,” Journal of Biological Chemistry, vol. 271, no. 18, pp. 10690–10696, 1996. View at Publisher · View at Google Scholar · View at Scopus
  111. J. A. McElhinny, S. A. Trushin, G. D. Bren, N. Chester, and C. V. Paya, “Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 899–906, 1996. View at Google Scholar · View at Scopus
  112. R. Lin, P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott, “Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability,” Molecular and Cellular Biology, vol. 16, no. 4, pp. 1401–1409, 1996. View at Google Scholar · View at Scopus
  113. E. M. Schwarz, D. van Antwerp, and I. M. Verma, “Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα,” Molecular and Cellular Biology, vol. 16, no. 7, pp. 3554–3559, 1996. View at Google Scholar · View at Scopus
  114. J. A. Brockman, D. C. Scherer, T. A. McKinsey et al., “Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation,” Molecular and Cellular Biology, vol. 15, no. 5, pp. 2809–2818, 1995. View at Google Scholar · View at Scopus
  115. K. Brown, S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist, “Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation,” Science, vol. 267, no. 5203, pp. 1485–1488, 1995. View at Google Scholar · View at Scopus
  116. E. B.-M. Traenckner, H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle, “Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli,” EMBO Journal, vol. 14, no. 12, pp. 2876–2883, 1995. View at Google Scholar · View at Scopus
  117. S. T. Whiteside, M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel, “N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity,” Molecular and Cellular Biology, vol. 15, no. 10, pp. 5339–5345, 1995. View at Google Scholar · View at Scopus
  118. T. Leveillard and I. M. Verma, “Diverse molecular mechanisms of inhibition of NF-κB/DNA binding complexes by IκB proteins,” Gene Expression, vol. 3, no. 2, pp. 135–150, 1993. View at Google Scholar · View at Scopus
  119. C. Johnson, D. van Antwerp, and T. J. Hope, “An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα,” EMBO Journal, vol. 18, no. 23, pp. 6682–6693, 1999. View at Google Scholar · View at Scopus
  120. F. Arenzana-Seisdedos, P. Turpin, M. Rodriguez et al., “Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm,” Journal of Cell Science, vol. 110, no. 3, pp. 369–378, 1997. View at Google Scholar · View at Scopus
  121. G. Ghosh, G. van Duyne, S. Ghosh, and P. B. Sigler, “Structure of NF-κB p50 homodimer bound to a κB site,” Nature, vol. 373, no. 6512, pp. 303–310, 1995. View at Google Scholar · View at Scopus
  122. C. W. Muller, F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison, “Structure of the NF-κB p50 homodimer bound to DNA,” Nature, vol. 373, no. 6512, pp. 311–317, 1995. View at Google Scholar · View at Scopus
  123. A. A. Beg, S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin Jr., “IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention,” Genes & Development, vol. 6, no. 10, pp. 1899–1913, 1992. View at Google Scholar · View at Scopus
  124. T. Henkel, U. Zabel, K. van Zee, J. M. Muller, E. Fanning, and P. A. Baeuerle, “Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit,” Cell, vol. 68, no. 6, pp. 1121–1133, 1992. View at Publisher · View at Google Scholar · View at Scopus
  125. U. Zabel, T. Henkel, M. S. Silva, and P. A. Baeuerle, “Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus,” EMBO Journal, vol. 12, no. 1, pp. 201–211, 1993. View at Google Scholar · View at Scopus
  126. P. Dobrzanski, R.-P. Ryseck, and R. Bravo, “Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity,” EMBO Journal, vol. 13, no. 19, pp. 4608–4616, 1994. View at Google Scholar · View at Scopus
  127. S. Simeonidis, D. Stauber, G. Chen, W. A. Hendrickson, and D. Thanos, “Mechanisms by which IκB proteins control NF-κB activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 1, pp. 49–54, 1999. View at Publisher · View at Google Scholar · View at Scopus
  128. H. Suyang, R. Phillips, I. Douglas, and S. Ghosh, “Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB,” Molecular and Cellular Biology, vol. 16, no. 10, pp. 5444–5449, 1996. View at Google Scholar · View at Scopus
  129. S.-C. Sun, P. A. Ganchi, D. W. Ballard, and W. C. Greene, “NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway,” Science, vol. 259, no. 5103, pp. 1912–1915, 1993. View at Google Scholar · View at Scopus
  130. Q. Cheng, C. A. Cant, T. Moll et al., “NF-κB subunit-specific regulation of the IκBα promoter,” Journal of Biological Chemistry, vol. 269, no. 18, pp. 13551–13557, 1994. View at Google Scholar · View at Scopus
  131. P. J. Chiao, S. Miyamoto, and I. M. Verma, “Autoregulation of IκBα activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 28–32, 1994. View at Publisher · View at Google Scholar · View at Scopus
  132. F. Arenzana-Seisdedos, J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay, “Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB,” Molecular and Cellular Biology, vol. 15, no. 5, pp. 2689–2696, 1995. View at Google Scholar · View at Scopus
  133. J.-L. Luo, H. Kamata, and M. Karin, “IKK/NF-κB signaling: balancing life and death—a new approach to cancer therapy,” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2625–2632, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. P. Viatour, M.-P. Merville, V. Bours, and A. Chariot, “Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation,” Trends in Biochemical Sciences, vol. 30, no. 1, pp. 43–52, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  135. F. Mercurio, H. Zhu, B. W. Murray et al., “IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation,” Science, vol. 278, no. 5339, pp. 860–866, 1997. View at Publisher · View at Google Scholar · View at Scopus
  136. J. D. Woronicz, X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel, “IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK,” Science, vol. 278, no. 5339, pp. 866–869, 1997. View at Publisher · View at Google Scholar · View at Scopus
  137. E. Zandi, D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin, “The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation,” Cell, vol. 91, no. 2, pp. 243–252, 1997. View at Publisher · View at Google Scholar · View at Scopus
  138. D. M. Rothwarf, E. Zandi, G. Natoli, and M. Karin, “IKK-γ is an essential regulatory subunit of the IκB kinase complex,” Nature, vol. 395, no. 6699, pp. 297–300, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. S. Yamaoka, G. Courtois, C. Bessia et al., “Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation,” Cell, vol. 93, no. 7, pp. 1231–1240, 1998. View at Publisher · View at Google Scholar · View at Scopus
  140. F. Mercurio, B. W. Murray, A. Shevchenko et al., “IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex,” Molecular and Cellular Biology, vol. 19, no. 2, pp. 1526–1538, 1999. View at Google Scholar · View at Scopus
  141. K. H. Mellits, R. T. Hay, and S. Goodbourn, “Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB,” Nucleic Acids Research, vol. 21, no. 22, pp. 5059–5066, 1993. View at Google Scholar · View at Scopus
  142. C. F. Barroga, J. K. Stevenson, E. M. Schwarz, and I. M. Verma, “Constitutive phosphorylation of IκBα by casein kinase II,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7637–7641, 1995. View at Publisher · View at Google Scholar · View at Scopus
  143. R. Weil, C. Laurent-Winter, and A. Israel, “Regulation of IκBβ degradation: similarities to and differences from IκBα,” Journal of Biological Chemistry, vol. 272, no. 15, pp. 9942–9949, 1997. View at Publisher · View at Google Scholar · View at Scopus
  144. D. Krappmann, F. G. Wulczyn, and C. Scheidereit, “Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo,” EMBO Journal, vol. 15, no. 23, pp. 6716–6726, 1996. View at Google Scholar · View at Scopus
  145. S. Miyamoto, B. J. Seufzer, and S. D. Shumway, “Novel IκBα proteolytic pathway in WEHI231 immature B cells,” Molecular and Cellular Biology, vol. 18, no. 1, pp. 19–29, 1998. View at Google Scholar · View at Scopus
  146. R. J. Phillips and S. Ghosh, “Regulation of IκBβ in WEHI 231 mature B cells,” Molecular and Cellular Biology, vol. 17, no. 8, pp. 4390–4396, 1997. View at Google Scholar · View at Scopus
  147. S. D. Shumway and S. Miyamoto, “A mechanistic insight into a proteasome-independent constitutive inhibitor κBα (IκBα) degradation and nuclear factor κB (NF-κB) activation pathway in WEHI-231 B-cells,” Biochemical Journal, vol. 380, no. 1, pp. 173–180, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. S. D. Shumway, M. Maki, and S. Miyamoto, “The PEST domain of IκBα is necessary and sufficient for in vitro degradation by μ-calpain,” Journal of Biological Chemistry, vol. 274, no. 43, pp. 30874–39881, 1999. View at Publisher · View at Google Scholar · View at Scopus
  149. S. D. Shumway, C. M. Berchtold, M. N. Gould, and S. Miyamoto, “Evidence for unique calmodulin-dependent nuclear factor-κB regulation in WEHI-231 B cells,” Molecular Pharmacology, vol. 61, no. 1, pp. 177–185, 2002. View at Publisher · View at Google Scholar · View at Scopus
  150. Y. Jiang, J. D. Woronicz, W. Liu, and D. V. Goeddel, “Prevention of constitutive TNF receptor 1 signaling by silencer of death domains,” Science, vol. 283, no. 5401, pp. 543–546, 1999. View at Publisher · View at Google Scholar · View at Scopus
  151. J. Ninomiya-Tsuji, K. Kishimoto, A. Hiyama, J.-I. Inoue, Z. Cao, and K. Matsumoto, “The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway,” Nature, vol. 398, no. 6724, pp. 252–256, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  152. O. Takeuchi and S. Akira, “Toll-like receptors; their physiological role and signal transduction system,” International Immunopharmacology, vol. 1, no. 4, pp. 625–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  153. S. Nemoto, J. A. DiDonato, and A. Lin, “Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase,” Molecular and Cellular Biology, vol. 18, no. 12, pp. 7336–7343, 1998. View at Google Scholar · View at Scopus
  154. J. L. Ducut Sigala, V. Bottero, D. B. Young, A. Shevchenko, F. Mercurio, and I. M. Verma, “Activation of transcription factor NF-κB requiries ELKS, an IκB kinase regulatory subunit,” Science, vol. 304, no. 5679, pp. 1963–1967, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. C. H. Regnier, H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe, “Identification and characterization of an IκB kinase,” Cell, vol. 90, no. 2, pp. 373–383, 1997. View at Publisher · View at Google Scholar · View at Scopus
  156. J. A. DiDonato, M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin, “A cytokine-responsive IκB kinase that activates the transcription factor NF-κB,” Nature, vol. 388, no. 6642, pp. 548–554, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  157. E. Zandi and M. Karin, “Bridging the gap: composition, regulation, and physiological function of the IκB kinase complex,” Molecular and Cellular Biology, vol. 19, no. 7, pp. 4547–4551, 1999. View at Google Scholar · View at Scopus
  158. H. Nakano, M. Shindo, S. Sakon et al., “Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3537–3542, 1998. View at Google Scholar · View at Scopus
  159. C. Wu and S. Ghosh, “Differential phosphorylation of the signal-responsive domain of IκBα and IκBβ by IκB kinases,” Journal of Biological Chemistry, vol. 278, no. 34, pp. 31980–31987, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. E. Zandi, Y. Chen, and M. Karin, “Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate,” Science, vol. 281, no. 5381, pp. 1360–1363, 1998. View at Google Scholar · View at Scopus
  161. L. Ling, Z. Cao, and D. V. Goeddel, “Nf-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3792–3797, 1998. View at Publisher · View at Google Scholar · View at Scopus
  162. M. Delhase, M. Hayakawa, Y. Chen, and M. Karin, “Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation,” Science, vol. 284, no. 5412, pp. 309–313, 1999. View at Google Scholar · View at Scopus
  163. Y. Hu, V. Baud, M. Delhase et al., “Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase,” Science, vol. 284, no. 5412, pp. 316–320, 1999. View at Google Scholar · View at Scopus
  164. Z.-W. Li, W. Chu, Y. Hu et al., “The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis,” Journal of Experimental Medicine, vol. 189, no. 11, pp. 1839–1845, 1999. View at Publisher · View at Google Scholar · View at Scopus
  165. T. S. Doi, M. W. Marino, T. Takahashi et al., “Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 2994–2999, 1999. View at Publisher · View at Google Scholar · View at Scopus
  166. A. A. Beg and D. Baltimore, “An essential role for NF-κB in preventing TNF-α-induced cell death,” Science, vol. 274, no. 5288, pp. 782–784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  167. J. A. DiDonato, F. Mercurio, and M. Karin, “Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB,” Molecular and Cellular Biology, vol. 15, no. 3, pp. 1302–1311, 1995. View at Google Scholar · View at Scopus
  168. E. B.-M. Traenckner and P. A. Baeuerle, “Appearance of apparently ubiquitin-conjugated IκB-α during its phosphorylation-induced degradation in intact cells,” Journal of Cell Science, vol. 19, pp. 79–84, 1995. View at Google Scholar · View at Scopus
  169. Z. Chen, J. Hagler, V. J. Palombella et al., “Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway,” Genes & Development, vol. 9, no. 13, pp. 1586–1597, 1995. View at Google Scholar · View at Scopus
  170. I. Alkalay, A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah, “Stimulation-dependent IκBα phosphorylation marks the NF-κb inhibitor for degradation via the ubiquitin-proteasome pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 23, pp. 10599–10603, 1995. View at Publisher · View at Google Scholar · View at Scopus
  171. C.-C. H. Li, R.-M. Dai, and D. L. Longo, “Inactivation of NF-κB inhibitor IκBα: ubiquitin-dependent proteolysis and its degradation product,” Biochemical and Biophysical Research Communications, vol. 215, no. 1, pp. 292–301, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  172. A. Ciechanover, “The ubiquitin-proteasome proteolytic pathway,” Cell, vol. 79, no. 1, pp. 13–21, 1994. View at Publisher · View at Google Scholar · View at Scopus
  173. M. Hochstrasser, “Ubiquitin, proteasomes, and the regulation of intracellular protein degradation,” Current Opinion in Cell Biology, vol. 7, no. 2, pp. 215–223, 1995. View at Publisher · View at Google Scholar · View at Scopus
  174. A. Murray, “Cyclin ubiquitination: the destructive end of mitosis,” Cell, vol. 81, no. 2, pp. 149–152, 1995. View at Google Scholar · View at Scopus
  175. K. D. Wilkinson, “Ubiquitin-dependent signaling: the role of ubiquitination in the response of cells to their environment,” Journal of Nutrition, vol. 129, no. 11, pp. 1933–1936, 1999. View at Google Scholar · View at Scopus
  176. T. Henkel, T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle, “Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB,” Nature, vol. 365, no. 6442, pp. 182–185, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  177. S.-C. Sun, J. Elwood, C. Beraud, and W. C. Greene, “Human T-cell leukemia virus type I Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene,” Molecular and Cellular Biology, vol. 14, no. 11, pp. 7377–7384, 1994. View at Google Scholar · View at Scopus
  178. E. B.-M. Traenckner, S. Wilk, and P. A. Baeuerle, “A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB,” EMBO Journal, vol. 13, no. 22, pp. 5433–5441, 1994. View at Google Scholar · View at Scopus
  179. T. S. Finco, A. A. Beg, and A. S. Baldwin Jr., “Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 11884–11888, 1994. View at Publisher · View at Google Scholar · View at Scopus
  180. S. Miyamoto, M. Maki, M. J. Schmitt, M. Hatanaka, and I. M. Verma, “Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 26, pp. 12740–12744, 1994. View at Publisher · View at Google Scholar · View at Scopus
  181. Y.-C. Lin, K. Brown, and U. Siebenlist, “Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF- κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 2, pp. 552–556, 1995. View at Publisher · View at Google Scholar · View at Scopus
  182. I. Alkalay, A. Yaron, A. Hatzubai et al., “In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB,” Molecular and Cellular Biology, vol. 15, no. 3, pp. 1294–1301, 1995. View at Google Scholar · View at Scopus
  183. R. Hartmann-Petersen and C. Gordon, “Proteins interacting with the 26S proteasome,” Cellular and Molecular Life Sciences, vol. 61, no. 13, pp. 1589–1595, 2004. View at Google Scholar · View at Scopus
  184. V. J. Palombella, O. J. Rando, A. L. Goldberg, and T. Maniatis, “The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB,” Cell, vol. 78, no. 5, pp. 773–785, 1994. View at Publisher · View at Google Scholar · View at Scopus
  185. M. S. Rodriguez, J. Wright, J. Thompson et al., “Identification of lysine residues required for signal-induced ubiquitination and degradation of IκB-α in vivo,” Oncogene, vol. 12, no. 11, pp. 2425–2435, 1996. View at Google Scholar · View at Scopus
  186. J. M. Griscavage, S. Wilk, and L. J. Ignarro, “Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 8, pp. 3308–3312, 1996. View at Publisher · View at Google Scholar · View at Scopus
  187. D. C. Scherer, J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard, “Signal-induced degradation of IκBα requires site-specific ubiquitination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 11259–11263, 1995. View at Publisher · View at Google Scholar · View at Scopus
  188. L. Baldi, K. Brown, G. Franzoso, and U. Siebenlist, “Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IκB-α,” Journal of Biological Chemistry, vol. 271, no. 1, pp. 376–379, 1996. View at Publisher · View at Google Scholar · View at Scopus
  189. M. S. Rodriguez, I. Michalopoulos, F. Arenzana-Seisdedos, and R. T. Hay, “Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein,” Molecular and Cellular Biology, vol. 15, no. 5, pp. 2413–2419, 1995. View at Google Scholar · View at Scopus
  190. T. Aoki, Y. Sano, T. Yamamoto, and J.-I. Inoue, “The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IκBα,” Oncogene, vol. 12, no. 5, pp. 1159–1164, 1996. View at Google Scholar · View at Scopus
  191. S.-C. Sun, J. Elwood, and W. C. Greene, “Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 1058–1065, 1996. View at Google Scholar · View at Scopus
  192. J. DiDonato, F. Mercurio, C. Rosette et al., “Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation,” Molecular and Cellular Biology, vol. 16, no. 4, pp. 1295–1304, 1996. View at Google Scholar · View at Scopus
  193. E. W. Harhaj, S. B. Maggirwar, L. Good, and S.-C. Sun, “CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers,” Molecular and Cellular Biology, vol. 16, no. 12, pp. 6736–6743, 1996. View at Google Scholar · View at Scopus
  194. T. A. McKinsey, J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard, “Inactivation of IκBβ by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB,” Molecular and Cellular Biology, vol. 16, no. 5, pp. 2083–2090, 1996. View at Google Scholar · View at Scopus
  195. R. J. Dohmen, “SUMO protein modification,” Biochimica et Biophysica Acta, vol. 1695, no. 1–3, pp. 113–131, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  196. R. T. Hay, “SUMO: a history of modification,” Molecular Cell, vol. 18, no. 1, pp. 1–12, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  197. A. M. Mabb and S. Miyamoto, “SUMO and NF-κB ties,” Cellular and Molecular Life Sciences, vol. 64, no. 15, pp. 1979–1996, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  198. B. Liu and K. Shuai, “Regulation of the sumoylation system in gene expression,” Current Opinion in Cell Biology, vol. 20, no. 3, pp. 288–293, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  199. J. M. P. Desterro, M. S. Rodriguez, and R. T. Hay, “SUMO-1 modification of IκBα inhibits NF-κB activation,” Molecular Cell, vol. 2, no. 2, pp. 233–239, 1998. View at Google Scholar · View at Scopus
  200. M. S. Rodriguez, C. Dargemont, and R. T. Hay, “SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting,” Journal of Biological Chemistry, vol. 276, no. 16, pp. 12654–12659, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  201. D. Guo, M. Li, Y. Zhang et al., “A functional variant of SUMO4, a new IκBα modifier, is associated with type diabetes,” Nature Genetics, vol. 36, no. 8, pp. 837–841, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  202. C.-Y. Wang, P. Yang, M. Li, and F. Gong, “Characterization of a negative feedback network between SUMO4 expression and NFκB transcriptional activity,” Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 477–481, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  203. M. J. Matunis, E. Coutavas, and G. Blobel, “A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex,” Journal of Cell Biology, vol. 135, no. 6, pp. 1457–1470, 1996. View at Publisher · View at Google Scholar · View at Scopus
  204. R. Mahajan, C. Delphin, T. Guan, L. Gerace, and F. Melchior, “A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2,” Cell, vol. 88, no. 1, pp. 97–107, 1997. View at Google Scholar · View at Scopus
  205. S. Müller, M. J. Matunis, and A. Dejean, “Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus,” EMBO Journal, vol. 17, no. 1, pp. 61–70, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  206. J. H. Kim and S. H. Baek, “Emerging roles of desumoylating enzymes,” Biochimica et Biophysica Acta, vol. 1792, no. 3, pp. 155–162, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  207. K. M. Comerford, M. O. Leonard, J. Karhausen, R. Carey, S. P. Colgan, and C. T. Taylor, “Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 986–991, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  208. Q. Liu, J. Li, J. Khoury, S. P. Colgan, and J. C. Ibla, “Adenosine signaling mediates SUMO-1 modification of IκBα during hypoxia and reoxygenation,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13686–13695, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  209. S. Noso, H. Ikegami, T. Fujisawa et al., “Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes,” Diabetes, vol. 54, no. 12, pp. 3582–3586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  210. M. Tsurumaru, E. Kawasaki, H. Ida et al., “Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3138–3143, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  211. C.-Y. Wang and J.-X. She, “SUMO4 and its role in type 1 diabetes pathogenesis,” Diabetes/Metabolism Research and Reviews, vol. 24, no. 2, pp. 93–102, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  212. C. E. Jennings, C. J. Owen, V. Wilson, and S. H. S. Pearce, “No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease,” Clinical Endocrinology, vol. 62, no. 3, pp. 362–365, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  213. L. J. Gibbons, W. Thomson, E. Zeggini et al., “The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis,” Rheumatology, vol. 44, no. 11, pp. 1390–1393, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  214. J. Costas, E. Perez-Pampin, I. Ferreiros-Vidal et al., “SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis,” Journal of Rheumatology, vol. 33, no. 6, pp. 1048–1051, 2006. View at Google Scholar · View at Scopus
  215. G. Orozco, E. Sánchez, M. A. González-Gay et al., “SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population,” Journal of Rheumatology, vol. 33, no. 7, pp. 1235–1239, 2006. View at Google Scholar · View at Scopus
  216. G. Orozco, E. Sánchez, L. M. Gómez et al., “Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 65, no. 6, pp. 791–795, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  217. T. T. Huang, S. M. Wuerzberger-Davis, Z.-H. Wu, and S. Miyamoto, “Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress,” Cell, vol. 115, no. 5, pp. 565–576, 2003. View at Publisher · View at Google Scholar · View at Scopus
  218. S. M. Wuerzberger-Davis, Y. Nakamura, B. J. Seufzer, and S. Miyamoto, “NF-κB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage,” Oncogene, vol. 26, no. 5, pp. 641–651, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  219. A. M. Mabb, S. M. Wuerzberger-Davis, and S. Miyamoto, “PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress,” Nature Cell Biology, vol. 8, no. 9, pp. 986–993, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  220. N. D. Perkins, “Post-translational modifications regulating the activity and function of the nuclear factor κB pathway,” Oncogene, vol. 25, no. 51, pp. 6717–6730, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  221. M. Neumann and M. Naumann, “Beyond IκBs: alternative regulation of NF-κB activity,” FASEB Journal, vol. 21, no. 11, pp. 2642–2654, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  222. R. Marienfeld, F. Berberich-Siebelt, I. Berberich, A. Denk, E. Serfling, and M. Neumann, “Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control,” Oncogene, vol. 20, no. 56, pp. 8142–8147, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  223. H. J. Maier, R. Marienfeld, T. Wirth, and B. Baumann, “Critical role of RelB serine 368 for dimerization and p100 stabilization,” Journal of Biological Chemistry, vol. 278, no. 40, pp. 39242–39250, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  224. B. J. Druker, M. Neumann, K. Okuda, B. R. Franza Jr., and J. D. Griffin, “rel Is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils,” Journal of Biological Chemistry, vol. 269, no. 7, pp. 5387–5390, 1994. View at Google Scholar · View at Scopus
  225. C. Fognani, R. Rondi, A. Romano, and F. Blasi, “cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain,” Oncogene, vol. 19, no. 18, pp. 2224–2232, 2000. View at Google Scholar · View at Scopus
  226. A. G. Martin and M. Fresno, “Tumor necrosis factor-α activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24383–24391, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  227. S.-H. Yu, W.-C. Chiang, H.-M. Shih, and K.-J. Wu, “Stimulation of c-Rel transcriptional activity by PKA catalytic subunit β,” The Journal of Molecular Medicine, vol. 82, no. 9, pp. 621–628, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  228. J. Harris, S. Olière, S. Sharma et al., “Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKKε,” The Journal of Immunology, vol. 177, no. 4, pp. 2527–2535, 2006. View at Google Scholar · View at Scopus
  229. C. Sánchez-Valdepeñas, A. G. Martín, P. Ramakrishnan, D. Wallach, and M. Fresno, “NF-κB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity,” The Journal of Immunology, vol. 176, no. 8, pp. 4666–4674, 2006. View at Google Scholar · View at Scopus
  230. H. Guan, S. Hou, and R. P. Ricciardi, “DNA binding of repressor nuclear factor-κB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit,” Journal of Biological Chemistry, vol. 280, no. 11, pp. 9957–9962, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  231. A. Ray and K. E. Prefontaine, “Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 752–756, 1994. View at Google Scholar · View at Scopus
  232. E. Caldenhoven, J. Liden, S. Wissink et al., “Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids,” Molecular Endocrinology, vol. 9, no. 4, pp. 401–412, 1995. View at Google Scholar · View at Scopus
  233. R. I. Scheinman, A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin Jr., “Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors,” Molecular and Cellular Biology, vol. 15, no. 2, pp. 943–953, 1995. View at Google Scholar · View at Scopus
  234. J. Liden, I. Rafter, M. Truss, J.-A. Gustafsson, and S. Okret, “Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene,” Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 1008–1014, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  235. R. M. Nissen and K. R. Yamamoto, “The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain,” Genes & Development, vol. 14, no. 18, pp. 2314–2329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  236. C. Martens, S. Bilodeau, M. Maira, Y. Gauthier, and J. Drouin, “Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor,” Molecular Endocrinology, vol. 19, no. 4, pp. 885–897, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  237. H. M. Reichardt, K. H. Kaestner, J. Tuckermann et al., “DNA binding of the glucocorticoid receptor is not essential for survival,” Cell, vol. 93, no. 4, pp. 531–541, 1998. View at Publisher · View at Google Scholar · View at Scopus
  238. H. M. Reichardt, J. P. Tuckermann, M. Göttlicher et al., “Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor,” EMBO Journal, vol. 20, no. 24, pp. 7168–7173, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  239. N. Auphan, J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin, “Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis,” Science, vol. 270, no. 5234, pp. 286–290, 1995. View at Google Scholar · View at Scopus
  240. R. I. Scheinman, P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin Jr., “Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids,” Science, vol. 270, no. 5234, pp. 283–286, 1995. View at Google Scholar · View at Scopus
  241. C. Brostjan, J. Anrather, V. Csizmadia et al., “Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis,” Journal of Biological Chemistry, vol. 271, no. 32, pp. 19612–19616, 1996. View at Publisher · View at Google Scholar · View at Scopus
  242. S. Heck, K. Bender, M. Kullmann, M. Göttlicher, P. Herrlich, and A. C. B. Cato, “IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor,” EMBO Journal, vol. 16, no. 15, pp. 4698–4707, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  243. R. Newton, L. A. Hart, D. A. Stevens et al., “Effect of dexamethasone on interleukin-1β-(IL-1β)-induced nuclear factor-κB (NF-κB) and κB-dependent transcription in epithelial cells,” The European Journal of Biochemistry, vol. 254, no. 1, pp. 81–89, 1998. View at Google Scholar · View at Scopus
  244. S. Wissink, E. C. van Heerde, B. van der Burg, and P. T. van der Saag, “A dual mechanism mediates repression of NF-κB activity by glucocorticoids,” Molecular Endocrinology, vol. 12, no. 3, pp. 355–363, 1998. View at Google Scholar · View at Scopus
  245. K. de Bosscher, W. Vanden Berghe, and G. Haegeman, “The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression,” Endocrine Reviews, vol. 24, no. 4, pp. 488–522, 2003. View at Publisher · View at Google Scholar · View at Scopus
  246. K. Ito, P. J. Barnes, and I. M. Adcock, “Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12,” Molecular and Cellular Biology, vol. 20, no. 18, pp. 6891–6903, 2000. View at Publisher · View at Google Scholar · View at Scopus
  247. K. Ito, S. Yamamura, S. Essilfie-Quaye et al., “Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression,” The Journal of Experimental Medicine, vol. 203, no. 1, pp. 7–13, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  248. M. Kagoshima, T. Wilcke, K. Ito et al., “Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation,” The European Journal of Pharmacology, vol. 429, no. 1–3, pp. 327–334, 2001. View at Publisher · View at Google Scholar · View at Scopus
  249. S. Saccani, S. Pantano, and G. Natoli, “p38-dependent marking of inflammatory genes for increased NF-κB recruitment,” Nature Immunology, vol. 3, no. 1, pp. 69–75, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  250. M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, and R. Renkawitz, “RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 26238–26243, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  251. Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr., “Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors,” Molecular Endocrinology, vol. 18, no. 6, pp. 1376–1395, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  252. H. Garside, A. Stevens, S. Farrow et al., “Glucocorticoid ligands specify different interactions with NF-κB by allosteric effects on the glucocorticoid receptor DNA binding domain,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 50050–50059, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  253. K. Ronacher, K. Hadley, C. Avenant et al., “Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction,” Molecular and Cellular Endocrinology, vol. 299, no. 2, pp. 219–231, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  254. L. Hart, L. Sam, I. Adcock, P. J. Barnes, and K. F. Chung, “Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB in asthma,” The American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 224–231, 2000. View at Google Scholar · View at Scopus
  255. O. Kassel, A. Sancono, J. Kraötzschmar, B. Kreft, M. Stassen, and A. C. B. Cato, “Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1,” EMBO Journal, vol. 20, no. 24, pp. 7108–7116, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  256. M. Lasa, M. Brook, J. Saklatvala, and A. R. Clark, “Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38,” Molecular and Cellular Biology, vol. 21, no. 3, pp. 771–780, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  257. M. Lasa, S. M. Abraham, C. Boucheron, J. Saklatvala, and A. R. Clark, “Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38,” Molecular and Cellular Biology, vol. 22, no. 22, pp. 7802–7811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  258. Y. Engelbrecht, H. de Wet, K. Horsch, C. R. Langeveldt, F. S. Hough, and P. A. Hulley, “Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines,” Endocrinology, vol. 144, no. 2, pp. 412–422, 2003. View at Publisher · View at Google Scholar · View at Scopus
  259. W. Wu, S. Chaudhuri, D. R. Brickley, D. Pang, T. Karrison, and S. D. Conzen, “Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells,” Cancer Research, vol. 64, no. 5, pp. 1757–1764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  260. R. Fürst, T. Schroeder, H. M. Eilken et al., “MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium,” FASEB Journal, vol. 21, no. 1, pp. 74–80, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  261. I. J. Cho and S. G. Kim, “A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR,” Molecular Endocrinology, vol. 23, no. 1, pp. 86–99, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  262. L.-G. Bladh, K. Johansson-Haque, I. Rafter, S. Nilsson, and S. Okret, “Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-κB activity by glucocorticoids,” Biochimica et Biophysica Acta, vol. 1793, no. 3, pp. 439–446, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  263. E. M. King, N. S. Holden, W. Gong, C. F. Rider, and R. Newton, “Inhibition of NF-κB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occuring via p38 MAPK,” Journal of Biological Chemistry, vol. 284, no. 39, pp. 26803–26815, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  264. H.-S. Ro, S.-W. Kim, D. Wu, C. Webber, and T. E. Nicholson, “Gene structure and expression of the mouse adipocyte enhancer-binding protein,” Gene, vol. 280, no. 1-2, pp. 123–133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  265. A. Majdalawieh, L. Zhang, I. V. Fuki, D. J. Rader, and H.-S. Ro, “Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2346–2351, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  266. A. Majdalawieh, L. Zhang, and H.-S. Ro, “Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-κB via IκBα negative regulation,” Molecular Biology of the Cell, vol. 18, no. 3, pp. 930–942, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  267. A. Majdalawieh and H.-S. Ro, “LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 7, pp. 1518–1525, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  268. S. E. Reznik and L. D. Fricker, “Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding,” Cellular and Molecular Life Sciences, vol. 58, no. 12-13, pp. 1790–1804, 2001. View at Google Scholar · View at Scopus
  269. X. Xin, R. Day, W. Dong, Y. Lei, and L. D. Fricker, “Identification of mouse CPX-2, a novel member of the metallocarboxypeptidase gene family: cDNA cloning, mRNA distribution, and protein expression and characterization,” DNA and Cell Biology, vol. 17, no. 10, pp. 897–909, 1998. View at Google Scholar · View at Scopus
  270. Y. Lei, X. Xin, D. Morgan, J. E. Pintar, and L. D. Fricker, “Identification of mouse CPX-1, a novel member of the metallocarboxypeptidase gene family with highest similarity to CPX-2,” DNA and Cell Biology, vol. 18, no. 2, pp. 175–185, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  271. G.-P. He, A. Muise, A. W. Li, and H.-S. Ro, “A eukaryotic transcriptional repressor with carboxypeptidase activity,” Nature, vol. 378, no. 6552, pp. 92–96, 1995. View at Google Scholar · View at Scopus
  272. A. M. Muise and H.-S. Ro, “Enzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNA,” Biochemical Journal, vol. 343, no. 2, pp. 341–345, 1999. View at Publisher · View at Google Scholar · View at Scopus
  273. S.-W. Kim, A. M. Muise, P. J. Lyons, and H.-S. Ro, “Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation,” Journal of Biological Chemistry, vol. 276, no. 13, pp. 10199–10206, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  274. P. J. Lyons, A. M. Muise, and H.-S. Ro, “MAPK modulates the DNA binding of adipocyte enhancer-binding protein 1,” Biochemistry, vol. 44, no. 3, pp. 926–931, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  275. L. Zhang, S. P. Reidy, T. E. Nicholson et al., “The role of AEBP1 in sex-specific diet-induced obesity,” Molecular Medicine, vol. 11, no. 1–12, pp. 39–47, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  276. H.-S. Ro, L. Zhang, A. Majdalawieh et al., “Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis,” Obesity, vol. 15, no. 2, pp. 288–302, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  277. S. J. Mansour, W. T. Matten, A. S. Hermann et al., “Transformation of mammalian cells by constitutively active MAP kinase kinase,” Science, vol. 265, no. 5174, pp. 966–970, 1994. View at Google Scholar · View at Scopus
  278. M. G. Wilkinson and J. B. A. Millar, “Control of the eukaryotic cell cycle by MAP kinase signaling pathways,” FASEB Journal, vol. 14, no. 14, pp. 2147–2157, 2000. View at Google Scholar · View at Scopus
  279. L. C. Platanias, “Map kinase signaling pathways and hematologic malignancies,” Blood, vol. 101, no. 12, pp. 4667–4679, 2003. View at Google Scholar · View at Scopus
  280. P. P. Roux and J. Blenis, “ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions,” Microbiology and Molecular Biology Reviews, vol. 68, no. 2, pp. 320–344, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  281. S. D. Rosen, J. A. Kafka, D. L. Simpson, and S. H. Barondes, “Developmentally regulated, carbohydrate binding protein in Dictyostelium discoideum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 70, no. 9, pp. 2554–2557, 1973. View at Google Scholar · View at Scopus
  282. W. R. Springer, D. N. W. Cooper, and S. H. Barondes, “Discoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideum and resembles fibronectin,” Cell, vol. 39, no. 3, pp. 557–564, 1984. View at Google Scholar · View at Scopus
  283. J. D. Johnson, J. C. Edman, and W. J. Rutter, “A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 12, pp. 5677–5681, 1993. View at Google Scholar · View at Scopus
  284. S. Prag, G. D. M. Collett, and J. C. Adams, “Molecular analysis of muskelin identifies a conserved discoidin-like domain that contributes to protein self-association,” Biochemical Journal, vol. 381, no. 2, pp. 547–559, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  285. P. Delerive, P. Gervois, J.-C. Fruchart, and B. Staels, “Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators,” Journal of Biological Chemistry, vol. 275, no. 47, pp. 36703–36707, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  286. M. Azuma, K. Motegi, K. Aota, T. Yamashita, H. Yoshida, and M. Sato, “TGF-β1 inhibits NF-κB activity through induction of IκB-α expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-β1,” Experimental Cell Research, vol. 250, no. 1, pp. 213–222, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  287. B. Saile, N. Matthes, H. El Armouche, K. Neubauer, and G. Ramadori, “The bcl, NF-κB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGFb or TNFα on activated hepatic stellate cells,” The European Journal of Cell Biology, vol. 80, no. 8, pp. 554–561, 2001. View at Google Scholar · View at Scopus
  288. J.-G. Park, A. Muise, G.-P. He, S.-W. Kim, and H.-S. Ro, “Transcriptional regulation by the γ5 subunit of a heterotrimeric G protein during adipogenesis,” EMBO Journal, vol. 18, no. 14, pp. 4004–4012, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  289. W. H. Kane and E. W. Davie, “Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 18, pp. 6800–6804, 1986. View at Google Scholar · View at Scopus
  290. J. D. Stubbs, C. Lekutis, K. L. Singer et al., “cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8417–8421, 1990. View at Google Scholar · View at Scopus
  291. C. Vijayasarathy, Y. Takada, Y. Zeng, R. A. Bush, and P. A. Sieving, “Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations,” Investigative Ophthalmology and Visual Science, vol. 48, no. 3, pp. 991–1000, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  292. A. Arakawa, M. Matsuo-Takasaki, A. Takai et al., “The secreted EGF-Discoidin factor xDel1 is essential for dorsal development of the Xenopus embryo,” Developmental Biology, vol. 306, no. 1, pp. 160–169, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  293. S. Baumgartner, K. Hofmann, R. Chiquet-Ehrismann, and P. Bucher, “The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction,” Protein Science, vol. 7, no. 7, pp. 1626–1631, 1998. View at Google Scholar · View at Scopus
  294. R. Sen and D. Baltimore, “Multiple nuclear factors interact with the immunoglobulin enhancer sequences,” Cell, vol. 46, no. 5, pp. 705–716, 1986. View at Google Scholar · View at Scopus
  295. J. E. Thompson, R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh, “IκB-β regulates the persistent response in a biphasic activation of NF-κB,” Cell, vol. 80, no. 4, pp. 573–582, 1995. View at Google Scholar · View at Scopus
  296. J.-I. Inoue, L. D. Kerr, A. Kakizuka, and I. M. Verma, “IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family,” Cell, vol. 68, no. 6, pp. 1109–1120, 1992. View at Publisher · View at Google Scholar · View at Scopus
  297. S. T. Whiteside, J.-C. Epinat, N. R. Rice, and A. Israeöl, “IκBε, a novel member of the IκB family, controls RelA and cRel NF-κB activity,” EMBO Journal, vol. 16, no. 6, pp. 1413–1426, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  298. G. P. Nolan, T. Fujita, K. Bhatia et al., “The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation- dependent manner,” Molecular and Cellular Biology, vol. 13, no. 6, pp. 3557–3566, 1993. View at Google Scholar · View at Scopus
  299. F. Mercurio, J. A. DiDonato, C. Rosette, and M. Karin, “p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction,” Genes & Development, vol. 7, no. 4, pp. 705–718, 1993. View at Google Scholar · View at Scopus
  300. T. Fujita, G. P. Nolan, S. Ghosh, and D. Baltimore, “Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB,” Genes & Development, vol. 6, no. 5, pp. 775–787, 1992. View at Google Scholar · View at Scopus
  301. R. Lin, D. Gewert, and J. Hiscott, “Differential transcriptional activation in vitro by NF-κB/Rel proteins,” Journal of Biological Chemistry, vol. 270, no. 7, pp. 3123–3131, 1995. View at Publisher · View at Google Scholar · View at Scopus
  302. J. L. Pomerantz, E. M. Denny, and D. Baltimore, “CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex,” EMBO Journal, vol. 21, no. 19, pp. 5184–5194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  303. G. Chinetti, S. Griglio, M. Antonucci et al., “Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25573–25580, 1998. View at Publisher · View at Google Scholar · View at Scopus
  304. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  305. Y.-C. Zhou and D. J. Waxman, “Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways: growth hormone inhibition of PPARα transcriptional activity mediated by STAT5b,” Journal of Biological Chemistry, vol. 274, no. 5, pp. 2672–2681, 1999. View at Publisher · View at Google Scholar · View at Scopus
  306. D. S. Straus, G. Pascual, M. Li et al., “15-deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 9, pp. 4844–4849, 2000. View at Google Scholar · View at Scopus
  307. S. B. Joseph, A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz, “Reciprocal regulation of inflammation and lipid metabolism by liver X receptors,” Nature Medicine, vol. 9, no. 2, pp. 213–219, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  308. A. Castrillo, S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz, “Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages,” Journal of Biological Chemistry, vol. 278, no. 12, pp. 10443–10449, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  309. J. S. Welch, M. Ricote, T. E. Akiyama, F. J. Gonzalez, and C. K. Glass, “PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFNγ target genes in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6712–6717, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  310. L. Chang, Z. Zhang, W. Li, J. Dai, Y. Guan, and X. Wang, “Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-κB pathway,” Biochemical and Biophysical Research Communications, vol. 357, no. 3, pp. 772–778, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  311. T. L. Bonfield, M. J. Thomassen, C. F. Farver et al., “Peroxisome proliferator-activated receptor-γ regulates the expression of alveolar macrophage macrophage colony-stimulating factor,” The Journal of Immunology, vol. 181, no. 1, pp. 235–242, 2008. View at Google Scholar · View at Scopus
  312. S. J. Park, K. S. Lee, S. R. Kim et al., “Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation,” The Journal of Immunology, vol. 183, no. 5, pp. 3259–3267, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  313. S. W. Chung, B. Y. Kang, S. H. Kim et al., “Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB,” Journal of Biological Chemistry, vol. 275, no. 42, pp. 32681–32687, 2000. View at Google Scholar · View at Scopus
  314. R. Weil, H. Sirma, C. Giannini et al., “Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα,” Molecular and Cellular Biology, vol. 19, no. 9, pp. 6345–6354, 1999. View at Google Scholar
  315. H. Gao, Y. Sun, Y. Wu et al., “Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways,” Molecular Cell, vol. 14, no. 3, pp. 303–317, 2004. View at Publisher · View at Google Scholar
  316. D.-K. Lee, J.-E. Kang, H.-J. Park et al., “FBI-1 enhances transcription of the nuclear factor-κB (NF-κB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-κB,” Journal of Biological Chemistry, vol. 280, no. 30, pp. 27783–27791, 2005. View at Publisher · View at Google Scholar · View at PubMed
  317. G. Le Negrate, A. Krieg, B. Faustin et al., “ChlaDub1 of Chlamydia trachomatis suppresses NF-κB activation and inhibits IκBα ubiquitination and degradation,” Cellular Microbiology, vol. 10, no. 9, pp. 1879–1892, 2008. View at Publisher · View at Google Scholar · View at PubMed
  318. D. Sorriento, M. Ciccarelli, G. Santulli et al., “The G-protein-coupled receptor kinase 5 inhibits NFκB transcriptional activity by inducing nuclear accumulation of IκBα,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 46, pp. 17818–17823, 2008. View at Publisher · View at Google Scholar · View at PubMed
  319. V. Doceul, B. Charleston, H. Crooke, E. Reid, P. P. Powell, and J. Seago, “The Npro product of classical swine fever virus interacts with IκBα, the NF-κB inhibitor,” The Journal of General Virology, vol. 89, no. 8, pp. 1881–1889, 2008. View at Publisher · View at Google Scholar · View at PubMed
  320. E. B. Kopp and R. Medzhitov, “The Toll-receptor family and control of innate immunity,” Current Opinion in Immunology, vol. 11, no. 1, pp. 13–18, 1999. View at Publisher · View at Google Scholar
  321. G. Zhang and S. Ghosh, “Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors,” The Journal of Endotoxin Research, vol. 6, no. 6, pp. 453–457, 2000. View at Publisher · View at Google Scholar